Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. reports developments tied to its national behavioral healthcare services business. The company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and outpatient behavioral health clinics serving communities in the United States and Puerto Rico.
Recurring news for ACHC includes quarterly operating results, same-facility revenue, patient days, admissions, revenue per patient day, adjusted EBITDA guidance and performance across its facility categories. Company updates also cover facility network changes, investor conference participation, board composition, executive leadership transitions and operational initiatives in behavioral healthcare and recovery services.
Acadia Healthcare (NASDAQ: ACHC) reported second quarter 2026 revenue of $865.8 million, roughly flat year over year, but up 2.8% after normalizing for prior-period supplemental payment programs. Same-facility revenue was flat as patient days rose 0.8% and revenue per patient day fell 0.8% due to timing of state supplemental payments.
Net income attributable to Acadia declined to $10.9 million ($0.12 diluted EPS) from $30.1 million ($0.33), while adjusted net income fell to $35.1 million ($0.38 EPS) from $74.8 million ($0.83). Adjusted EBITDA decreased to $149.2 million from $201.8 million, reflecting a $28.6 million increase to professional and general liability reserves and lower supplemental payment benefits, partly offset by a $26.1 million Florida program benefit. Operating cash flow improved to $162.1 million versus $133.5 million, with capital expenditures down to $38.6 million from $167.7 million.
Acadia added 240 licensed beds via two new joint venture hospitals and opened two new comprehensive treatment centers. As of June 30, 2026, it held $171.3 million in cash, $669.8 million of revolver availability and reported net leverage of 4.1x Adjusted EBITDA. The company raised its full-year 2026 guidance, now expecting revenue of $3.40–$3.45 billion, Adjusted EBITDA of $590–$615 million, adjusted EPS of $1.45–$1.60, operating cash flow of $350–$400 million, and reduced capital expenditures to $235–$255 million.
Acadia Healthcare (NASDAQ: ACHC) will release its second quarter 2026 earnings on Tuesday, July 28, 2026, after market close. The company will host an investor conference call on Wednesday, July 29, 2026, at 9:00 a.m. ET, with a live and archived webcast on its investor website.
Acadia Healthcare (NASDAQ: ACHC) reported Q1 2026 revenue of $828.8 million, up 7.6% year-over-year, and Adjusted EBITDA of $144.2 million. The company raised full-year 2026 Adjusted EBITDA and Adjusted EPS guidance, now targeting $580–$615 million Adjusted EBITDA and $1.35–$1.60 Adjusted EPS.
Q1 results included same-facility revenue +7.3%, added 82 licensed beds, cash of $158.5 million, and net leverage of 3.9x Adjusted EBITDA as of March 31, 2026.
National Veterinary Associates (ACHC) named Todd S. Young as Chief Financial Officer, effective May 1, 2026. He will report to CEO John Bruno and join the executive leadership team. Young brings more than 25 years in human and animal healthcare finance, including prior CFO roles at Acadia Healthcare (NASDAQ: ACHC) and Elanco (NYSE: ELAN).
Young said he looks forward to strengthening NVA's financial foundation as the company continues investing across its care network.
Acadia Healthcare (NASDAQ: ACHC) appointed David Duckworth as Interim Chief Financial Officer effective May 1, 2026, succeeding Todd Young, who will remain through April 30, 2026. The interim assignment will last at least until the completion of the ongoing CEO search.
The company reaffirms Q1 2026 guidance of revenue $820–$830 million, adjusted EBITDA $130–$137 million, adjusted EPS $0.25–$0.30, and full‑year 2026 guidance of revenue $3.37–$3.45 billion, adjusted EBITDA $575–$610 million, adjusted EPS $1.30–$1.55. Q1 results will be issued April 29; earnings call on April 30 at 9:00 a.m. ET.
Acadia Healthcare (NASDAQ: ACHC) will release its first quarter 2026 results on Wednesday, April 29, 2026, after market close. The company will host a conference call for institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET.
A live webcast will be available in Acadia's Investors section and the replay will remain accessible for 30 days.
Acadia Healthcare (NASDAQ: ACHC) appointed Daniel Cancelmi to its Board of Directors effective March 12, 2026, and announced director Wade D. Miquelon will not stand for re-election at the 2026 Annual Meeting. Cancelmi brings three decades of healthcare finance experience, most recently as CFO of Tenet Healthcare. The Board selection followed a search and engagement with Khrom Capital. Goldman Sachs and J.P. Morgan are financial advisors; Kirkland & Ellis is legal advisor.
Acadia Healthcare (NASDAQ: ACHC) reported Q4 2025 revenue of $821.5M (up 6.1% YoY) and full-year 2025 revenue of $3.313B (up 5.0%). The company recorded a non-cash $996.2M goodwill impairment, producing a GAAP net loss per diluted share of $13.02 for Q4.
Acadia posted Q4 Adjusted EBITDA of $99.8M and provided 2026 guidance: revenue $3.37–3.45B, Adjusted EBITDA $575–610M, and adjusted EPS $1.30–1.55.
Acadia Healthcare (NASDAQ: ACHC) will participate in three investor conferences in March 2026 with scheduled presentations and live webcasts. Presentations: Raymond James on March 2 at 11:35 a.m. ET, Leerink on March 9 at 3:40 p.m. ET, and Barclays on March 10 at 12:00 p.m. ET.
A live webcast and a replay available for 30 days will be accessible via the company website under the Investors section.
Acadia Healthcare (NASDAQ: ACHC) will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens.
The company will host a conference call with institutional investors and analysts on February 25, 2026 at 9:00 a.m. ET, with a live webcast available on the company’s Investors page and a replay for 30 days.